+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glatiramer Acetate"

From
From
Multiple sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Glatiramer acetate is a synthetic drug used to treat multiple sclerosis (MS). It is a mixture of four amino acids that are similar to those found in myelin, the protective sheath that covers nerve fibers. The drug works by reducing the inflammation and damage to the myelin sheath caused by MS. It is administered as an injection and is usually taken once a day. Glatiramer acetate is a relatively new drug, but it has become increasingly popular in the Central Nervous System (CNS) drugs market. It is used to treat relapsing-remitting MS, a form of the disease that is characterized by periods of remission and relapse. It is also used to treat primary progressive MS, a form of the disease that is characterized by a gradual worsening of symptoms. Glatiramer acetate is available in both generic and branded forms. Some of the companies that produce glatiramer acetate include Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more